Leif Helth Jensen

Cureon A/S is a Danish biotech company that owns the pharmaceutical rights to a novel DNA analogue, termed LNA (Locked Nucleic Acid) which displays unprecedented affinity compared to all other DNA chemistries. The company believes that the unique properties of this novel analogue will enable oligonucleotide based therapeutics (Antisense therapy) to enter main-stream pharmaceuticals.

Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark.

Medi Telecom SA engages in the provision of wireless telecommunications services. The company was founded in 1999 and is headquartered in Casablanca, Morocco.

Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.

Alcorlab A/S manufactures peptide synthesizers. It develops an apparatus that can synthesize oligonucleotides, LNA´s, DNA's, RNA's, and peptides. The company is headquartered in Vaerloese, Denmark.

Global Aviation Data A/S develops system for managing the risk of overexposure to cosmic radiation during air transportation. Its system is designed to help frequent flyers and airlines to manage and minimize their risk of overexposure to radiation. The firm also handles the administrative and reporting procedures necessary to comply with existing and future national and international legislation and regulation concerning cosmic radiation. The company was founded by Peer Widar Wollenberg on July 4, 2003 and is headquartered in Klampenborg, Denmark.

Thrombologic ApS provides medical research and develops therapeutics. The firm develops a new therapy for prevention and treatment of multiple organ failure in Intensive care unit (ICU) patients. The company was founded in December 2009 and is headquartered in Copenhagen, Denmark.

DentoFit A/S develops non-shrinking composite resin material for dental plastic fillings. Its material is used as filler for dental restorative therapy. The company was founded by Per Bækgård in 2004 and is headquartered in Roskilde, Denmark.

BluSense Diagnostics ApS develops medical devices through connecting to cloud software. It offers BluBox, Viro-Track, and nanotechnology and microfluidics. The company was founded by Marco Donolato in 2014 and is headquartered in Copenhagen, Denmark.

UV Clinical ApS is a technology company, which engages in the development of devices using ultra-violet light emitting diodes for disinfection of medical implants. The company was founded by Leif Helth Jensen and Jimmy Bak and is headquartered in Greve, Denmark.